Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Ceenu
| Field | Information |
|---|---|
| Medication Name | Ceenu |
| Generic Name | Lomustine |
| Boxed/Label Warning | May cause delayed bone marrow suppression, pulmonary toxicity, and secondary malignancies. |
| Purpose | Chemotherapy medication used to treat certain types of brain tumors and Hodgkin’s lymphoma. |
| Mechanism of Action | Alkylating agent that interferes with DNA and RNA synthesis, inhibiting cell growth and division. |
| Dosage Forms | Oral capsules |
| Available Strengths | 10 mg, 40 mg, 100 mg |
| Dosage Frequency | Typically administered once every 6 weeks, or as directed by a healthcare provider. |
| Common Side Effects | Nausea, vomiting, loss of appetite, fatigue, hair loss, mouth sores. |
| Serious Side Effects | Bone marrow suppression (low blood counts), pulmonary fibrosis, liver damage, secondary malignancies. |
| Drug Interactions | Other chemotherapy drugs, drugs that suppress the immune system, live vaccines. |
| Important Notes | Monitor blood counts regularly; avoid live vaccines; use effective contraception during and after treatment. |
| Storage | Store capsules in a refrigerator between 36°F to 46°F (2°C to 8°C). Protect from light. |
| Missed Dose | Contact your healthcare provider immediately for instructions. Do not take a double dose. |
| Alternatives | Carmustine, Procarbazine, Temozolomide |
Ceenu Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Carmustine | Alkylating agent that forms DNA crosslinks. | Another chemotherapy drug used for brain tumors and lymphoma. |
| Procarbazine | Inhibits DNA, RNA, and protein synthesis. | Used in combination with other drugs to treat Hodgkin’s lymphoma and brain tumors. |
| Temozolomide | Alkylating agent that damages DNA. | Oral chemotherapy drug used to treat glioblastoma multiforme and anaplastic astrocytoma. |
Ceenu Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Bone marrow suppression (anemia, thrombocytopenia, leukopenia) |
| Vomiting | Pulmonary fibrosis |
| Loss of appetite | Liver damage |
| Fatigue | Secondary malignancies (leukemia, myelodysplastic syndrome) |
| Hair loss | Increased risk of infection |
| Mouth sores | Neurological effects (confusion, seizures) |
Ceenu Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Brain Tumors | 130 mg/m² | Repeat every 6 weeks | Administered as a single dose. Adjust based on blood counts. |
| Hodgkin’s Lymphoma | 75-100 mg/m² | Repeat every 6 weeks | Administered as a single dose. Adjust based on blood counts. |
Ceenu Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $50 – $200 |
| From Canada |
